Diagonal Bio

📍 Lund, Sweden🗓 Founded 2020👥 12 employees💰 Last funded Oct 2020
Biotechnology🌐 diagonalbio.com
Website LinkedIn
Diagonal Bio develops a ground-breaking platform for fast, simple and reliable pathogen diagnostics. The company was founded at the onset of the covid-19 pandemic in 2020 with the express goal to revolutionise diagnosis of infectious diseases. Diagonal Bio is led by COB Eva Nilsagård, CEO Jack Egelund Madsen, CSO Andreas Nyberg, and CFO Per Heander. Diagonals operations are based in Lund, Sweden and its scientific advisors include Prof. Vicent Pelechano (Karolinska Institute, Sweden), Prof. Christelle Prinz (Lund University, Sweden), Prof. Patrik Medstrand (Lund University), Prof. Tautgirdas Ruzgas (Malmö University, Sweden) and Kushagr Punyani (Spermosens AB). www.diagonalbio.com
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Denmark
1
Sweden
1
Frequently asked questions
Who invested in Diagonal Bio?
Diagonal Bio has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Diagonal Bio last raise funding?
The most recent investment in Diagonal Bio recorded on gritt.io was in October 2020.
When was Diagonal Bio founded?
Diagonal Bio was founded in 2020.
What industry is Diagonal Bio in?
Diagonal Bio operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Diagonal Bio based?
Diagonal Bio is headquartered in Lund, Sweden.